Amylyx Pharmaceuticals stock price
아밀릭스 파머슈티컬스NASDAQ:AMLX · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →Amylyx Pharmaceuticals last closed at $27.79 (-1.03%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -20.3×. Its overall grade ranks 111 of 739 stocks in Healthcare.
About this company
Amylyx Pharmaceuticals last closed at $27.79 (-1.03%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 111/739
Valuation grade A
Related stocks
- BiogenCompetitor
신경퇴행성 질환 치료제 개발·상업화 영역에서 직접 경쟁
- RocheCompetitor
알츠하이머 등 CNS/신경질환 파이프라인 경쟁사
- EisaiCompetitor
알츠하이머 치료제 시장에서 경쟁하는 주요 글로벌 제약사
ETFs holding this stock
SPDR S&P Pharmaceuticals ETF · Virtus LifeSci Biotech Clinical Trials ETF · Direxion Daily Pharmaceutical & Medical Bl 3X Shs
Details →About Amylyx Pharmaceuticals
- What technical signals does Amylyx Pharmaceuticals (AMLX) have?
- Amylyx Pharmaceuticals current technical signals: no active technical signal.
- Is Amylyx Pharmaceuticals a cup-and-handle pattern?
- No. Amylyx Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Amylyx Pharmaceuticals?
- Market cap: $3.05B. Trailing 12 months PER: -20.3×. Latest quarter PBR: 12.92×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Amylyx Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.